TDOC:NYE-Teladoc Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 9.21

Change

0.00 (0.00)%

Market Cap

N/A

Volume

6.59M

Analyst Target

USD 241.46
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-03 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

N/A

USD 10.78B
DOCS Doximity Inc

N/A

USD 7.80B
WEAV Weave Communications Inc

N/A

USD 1.02B
MPLN MultiPlan Corporation

N/A

USD 0.14B
AMWL American Well Corp

N/A

USD 0.14B
OWLT Owlet Inc

N/A

USD 0.08B
PHR Phreesia Inc

N/A

N/A
FOXO FOXO Technologies Inc.

N/A

N/A
EVH Evolent Health Inc

N/A

N/A
VEEV Veeva Systems Inc Class A

N/A

N/A

ETFs Containing TDOC

RWM ProShares Short Russell20.. 0.00 % 0.95 %

N/A

USD 0.16B
QBTL:CA AGFiQ US Market Neutral A.. 0.00 % 0.00 %

N/A

CAD 0.26B
CCON 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -57.26% 10% F 8% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return -57.26% 10% F 9% A-
Trailing 12 Months  
Capital Gain -47.01% 10% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -47.01% 10% F 10% F
Trailing 5 Years  
Capital Gain -88.50% 25% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -88.50% 25% F 3% F
Average Annual (5 Year Horizon)  
Capital Gain -30.99% 20% F 1% F
Dividend Return -30.99% 20% F 1% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 58.15% 80% B- 15% F
Risk Adjusted Return -53.29% 10% F 4% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.